Skip to main navigation Skip to search Skip to main content

Chlamydia in female reproductive tract

  • Deeksha Pandey*
  • , Jyoti Shetty
  • , Muralidhar V. Pai
  • , Pratapkumar
  • *Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

Abstract

Chlamydia trachomatis today has become the most common bacterial sexually transmitted infection (STI), all over the world. Most of the times it is asymptomatic in female reproductive tract; but if left untreated leads to dreaded consequences like pelvic inflammatory disease (PID), infertility, ectopic pregnancy and chronic pelvic pain. Advent of nucleic acid amplification tests (NAATs) for diagnosis coupled with introduction of single dose azithromycin therapy for treatment has shown high promises to fight against Chlamydial infection as well as to prevent its long term sequels.

Original languageEnglish
JournalInternet Journal of Infectious Diseases
Volume7
Issue number1
Publication statusPublished - 01-12-2009

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

All Science Journal Classification (ASJC) codes

  • Infectious Diseases
  • Microbiology (medical)

Fingerprint

Dive into the research topics of 'Chlamydia in female reproductive tract'. Together they form a unique fingerprint.

Cite this